Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma news india

    Tag: pharma news india

    You Searched For "pharma news india"
    Cipla gets 8 USFDA observations for Kurkumbh plant

    Cipla gets 8 USFDA observations for Kurkumbh plant

    Farhat Nasim1 April 2019 9:55 AM IST
    The inspection covered three units at the plant. Post the conclusion of the inspection, the company received 8 GMP observations. The company also...
    Lupin, Aurobindo Pharma recalls multiple lots of BP drug including VALSARTAN

    Lupin, Aurobindo Pharma recalls multiple lots of BP drug including VALSARTAN

    Farhat Nasim1 April 2019 9:50 AM IST
    Aurobindo Pharma is also recalling certain lots of Amlodipine and Valsartan Tablets USP 10mg/160mg in 30 count bottles for CGMP deviations.New Delhi:...
    Diabetes Treatment: CDSCO expert panel marketing authorization Nod to Glenmark

    Diabetes Treatment: CDSCO expert panel marketing authorization Nod to Glenmark's SGLT2 Inhibitor Remogliflozin etabonate

    Meghna A Singhania31 March 2019 1:39 PM IST
    New Delhi: Mumbai-based Glenmark Pharmaceuticals Limited recently received the permission from the IND Committee of the Central Drugs Standard...
    USFDA inspected Goa facility, no observations issued: Indoco Remedies

    USFDA inspected Goa facility, no observations issued: Indoco Remedies

    Farhat Nasim30 March 2019 11:52 AM IST
    The US Food and Drug Administration (USFDA) has cleared the Goa-based sterile manufacturing facility of Indoco Remedies for finished dosages.New...
    AstraZeneca, Daiichi Sankyo sign $6.9 billion cancer drug deal

    AstraZeneca, Daiichi Sankyo sign $6.9 billion cancer drug deal

    Garima29 March 2019 9:15 AM IST
    Under the deal, AstraZeneca will pay Daiichi up to $6.9 billion, including a $1.35 billion upfront payment. The two companies will share development...
    Dr Reddy

    Dr Reddy's launches Tadalafil Tablets to treat erectile dysfunction

    Farhat Nasim28 March 2019 12:06 PM IST
    Dr Reddy's Tadalafil tablets are available in four strengths including 2.5 mg, 5 mg, 10 mg, and 20 mg, each in 30-count bottle size.New Delhi: Dr...
    Manufacturers of SGLT2 inhibitor Drugs to have to INCLUDE safety WARNING in package: CDSCO

    Manufacturers of SGLT2 inhibitor Drugs to have to INCLUDE safety WARNING in package: CDSCO

    Farhat Nasim26 March 2019 1:28 PM IST
    New Delhi: Paying heed to the safety updates of Sodium-Glucose Cotransporter-2 (SGLT2) including medicines such as Canagliflozin, Dapagliflozin,...
    Lupin launches generic Levothyroxine Sodium tablets

    Lupin launches generic Levothyroxine Sodium tablets

    Farhat Nasim22 March 2019 11:30 AM IST
    Lupin's Levothyroxine Sodium tablet is the generic version of AbbVie Inc's Synthroid tablets, it added. New Delhi: Drug firm Lupin Friday said it has...
    Novartis division Alcon acquires Power Vision

    Novartis division Alcon acquires Power Vision

    Garima20 March 2019 9:47 AM IST
    Under the terms of the agreement, Alcon, a Novartis division paid USD 285 million to PowerVision at closing with additional payments based on...
    Merck, Enigma Biomedical signs license agreement for Novel MK 6884 Imaging Agent

    Merck, Enigma Biomedical signs license agreement for Novel MK 6884 Imaging Agent

    Garima20 March 2019 9:46 AM IST
    As part of the agreement with Merck, EBG will be responsible for the clinical development and commercialization of MK-6884 in return for payment of...
    Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution

    Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution

    Farhat Nasim17 Feb 2019 9:30 AM IST
    The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Olopatadine...
    Import of drugs in India: Center adds two more ports, Releases Gazette Notification

    Import of drugs in India: Center adds two more ports, Releases Gazette Notification

    Farhat Nasim13 Jan 2019 9:33 AM IST
    New Delhi: An upsurge in the import of drugs is likely to be seen as the government has recently informed about the addition of two new ports for this...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok